Revenue ₹2,752 Cr
Promise tracking available after 2+ quarters of coverage.
View all executive profiles for Piramal Pharma LtdPiramal Pharma reported a transitional FY26 with revenue decline due to inventory destocking in a key on-patent comme...
Quarterly Earnings Timeline
Financial verification status, call summary, sentiment, and management-delivery signals by quarter.